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Abstract
Concerns about the effects of bisphenol A (BPA) on human brain and behavior are not novel; however, Grohs and
colleagues have contributed groundbreaking data on this topic in a recent issue of Environmental Health. For the first time,
associations were reported between prenatal BPA exposure and differences in children’s brain microstructure, which
appeared to mediate the association between this exposure and children’s behavioral symptoms. Findings in numerous
previous mother-child cohorts have pointed in a similar worrying direction, linking higher BPA exposure during pregnancy
to more behavioral problems throughout childhood as assessed by neuropsychological questionnaires. Notwithstanding, this
body of work has not been adequately considered in risk assessment. From a toxicological perspective, results are now
available from the CLARITY-BPA consortium, designed to reconcile academic and regulatory toxicology findings. In fact, the
brain has consistently emerged as one of the most sensitive organs disrupted by BPA, even at doses below those
considered safe by regulatory agencies such as the European Food Safety Authority (EFSA). In this Commentary, we
contextualize the results of Grohs et al. within the setting of previous epidemiologic and CLARITY-BPA data and express our
disquiet about the “all-or-nothing” criterion adopted to select human data in a recent EFSA report on the appraisal
methodology for their upcoming BPA risk assessment. We discuss the most relevant human studies, identify emerging
patterns, and highlight the need for adequate assessment and interpretation of the increasing epidemiologic literature in this
field in order to support decision-making. With the aim of avoiding a myopic or biased selection of a few studies in
traditional risk assessment procedures, we propose a future reevaluation of BPA focused on neurotoxicity and based on a
systematic and comprehensive integration of available mechanistic, animal, and human data. Taken together, the
experimental and epidemiologic evidence converge in the same direction: BPA is a probable developmental neurotoxicant
at low doses. Accordingly, the precautionary principle should be followed, progressively implementing stringent preventive
policies worldwide, including the banning of BPA in food contact materials and thermal receipts, with a focus on the
utilization of safer substitutes.
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A key contribution to a hot topic
In a recent issue of Environmental Health, Grohs and
colleagues [1] examined whether prenatal BPA expos-
ure was associated with offspring’s brain microstruc-
ture and behavior in a sub-cohort of 98 mother-child
pairs from the Canadian Alberta Pregnancy Outcomes
and Nutrition (APrON) study. Healthy children, free
of any neurodevelopmental disorder, underwent a dif-
fusion magnetic resonance imaging (MRI) scan at 2–
5 years of age to assess white matter microstructure
in major brain regions. Seventy-seven out of the 98
initial children also had a postnatal urine sample col-
lected at 3–4 years, and 56 had the Child Behavior
Checklist (CBCL) test completed by their parents
within 6 months of the scan.
For the first time, Grohs and colleagues found that
higher maternal urinary BPA concentrations, at around
17 weeks of gestation, were associated with a less devel-
oped white matter in the splenium (subregion of corpus
callosum) and in the right inferior longitudinal fasciculus
(tract connecting the anterior temporal and occipital
lobes) [1]. Moreover, white matter differences in the
splenium mediated the association between prenatal
BPA exposure and children’s internalizing problems (e.g.
anxiety and depression symptoms). Postnatal urinary
BPA concentrations were not associated with either
brain microstructure or behavior [1].
The greatest strength and added value of the study
by Grohs et al. was the implementation of a quantita-
tive effect biomarker (MRI) to assess brain structure,
which indeed provided a neural correlate for altered
behavioral function in response to prenatal BPA ex-
posure, thus increasing the internal validity of the
findings. Collectively, these results suggest that pre-
natal -rather than postnatal- BPA exposure may shape
and “organize” offspring’s brain structure leading to
lasting adverse effects on children’s behavior. Among
the main limitations, the study analyzed a small sam-
ple size and characterized BPA exposure using only
one spot urine sample.
If this was the first epidemiologic study to report a
potential effect of prenatal BPA exposure on
children’s behavior, we should be cautious interpret-
ing these results. However, this is far from reality:
many previous mother-child cohorts, with small,
medium and large sample sizes have reported quite
consistent associations between prenatal BPA expos-
ure and a higher risk of subclinical behavioral prob-
lems throughout childhood, as reviewed by Mustieles
et al. and Ejaredar et al. [2, 3]. Importantly, the quan-
tifiable measure of children’s brain structure imple-
mented by Grohs and colleagues provides support to
previous associations observed using validated neuro-
psychological questionnaires.
Emerging patterns in a growing literature
Numerous mother-child cohorts have studied the
relationship between prenatal urinary BPA concentra-
tions and children’s behavior (Table 1) [2, 3]. Overall,
most of them have reported associations between higher
prenatal BPA exposure and at least one behavioral do-
main (internalizing, externalizing or both) [2, 3]. Al-
though reported associations with internalizing and
externalizing behaviors is usually considered as an in-
consistency across studies, this aspect is in line with
toxicological studies in which both types of behaviors
have been reported in response to BPA exposure [2, 4].
Only a few prenatal studies (3 out of 13 cohorts) did not
report any association, probably due to their small sam-
ple size and/or age at behavior assessment (Table 1).
The findings by Grohs at al. reinforce that the prenatal
period is the most critical window of BPA exposure for
behavior, in line with previous studies (Supplemental
Table 2), suggesting an organizational effect in the fetal
brain [1]. Although prenatal BPA exposure was signifi-
cantly associated with increased internalizing problems
in the APrON cohort, an imprecise but potential associ-
ation towards externalizing problems was also apparent
and cannot be ruled out based on the small sample size
of the population studied [1].
Most of the previous prenatal studies also reported
sex-specific associations (Table 1). This in line with ro-
dent studies, that have shown effects in females, males
or both depending on the behavioral outcome studied
and/or timing of BPA exposure [4]. In humans, prenatal
associations were mainly -but not uniquely- reported
among boys (Table 1). Grohs et al. however, did not find
sex-specific associations with either children’s brain
structure or behavior [1]. Nonetheless, this possibility
cannot be ruled out based on the small sample size ana-
lyzed, likely underpowered compared to previous
mother-child cohorts. Additional observational studies
are needed to further confirm patterns of sex-specific
associations.
Cognitive and other behavioral domains including ex-
ternalizing, internalizing, emotional and social problems
have been assessed in relation to prenatal and/or postna-
tal BPA exposure (Supplemental Table 3). While fre-
quent associations have been reported between pre- and
postnatal exposure and externalizing/internalizing be-
haviors, relations with cognitive outcomes have been
largely null, with the potential exception of poorer work-
ing memory in a few studies, as discussed in detail in
Rodríguez-Carrillo et al. [5] (Supplemental Table 3).
Interestingly, the difference between cognitive and other
behavioral outcomes cannot be explained by chance
alone, and could be in line with the known ability of
BPA to alter the expression of estrogenic nuclear recep-
tors in the brain, leading to a predominant impact on
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Table 1 Summary of main results reported in mother-child cohorts addressing the relationship between prenatal urinary BPA
concentrations and children’s behavior
Cohort study Sample
size





249 3 (gestation weeks 16th and
26th, and delivery)
Yes Externalizing at 2 yrs. Girls
Braun et al.,
2011
244 Yes Internalizing at 3 yrs.
Braun et al.,
2014
175 2 (gestation weeks 16th and
26th)
No Autistic behaviors at 4–5 yrs. n/a
Braun et al.,
2017
178 2 (gestation weeks 16th and
26th)
Yes Externalizing behavior trajectory





137 1 (gestation week 31th) No
(Yes, when 6 outliers were removed
from the analysis)




198 1 (gestation week 34th) Yes Both at 3–5 yrs. Boys
Roen et al.,
2015
250 Yes Both at 7–9 yrs.
Perera et al.,
2016





292 2 (gestation weeks 14th and
26th)





















812 1 (gestation week 12th) Yes Internalizing at 3 yrs. Boys
EDC (Korea)
Lim et al., 2017





658 1 (gestation week 28th) No At 2–4 yrs. n/a
CHECK (Korea)
Kim et al., 2018





98 1 (gestation week 17th) Yes Internalizing at 4–5 yrs. Both
S-MBCS
(China)
Li et al., 2020
745 1 (gestation weeks 12th–16th) Yes Both at 2–4 yrs. Boys
For conciseness and due to space limitations, all references included in this table can be consulted in the Supplemental Table 1 of the Supplementary
Appendix. *A p-value ≤ 0.05 defined the existence of an association. However, other parameters such as the internal validity of associations were also
considered. n/a Not applicable, since no association was reported. APrON Alberta Pregnancy Outcomes and Nutrition, CHAMACOS Center for the Health
Assessment of Mothers and Children of Salinas, CHECK Children’s Health and Environmental Chemicals in Korea, CCCEH Columbia Center for Children’s
Environmental Health, EDC Environment and Development of Children, EDEN Study on the Pre- and Early Postnatal Determinants of Child Health and
Development, HOME Health Outcomes and Measures of the Environment Study, INMA Environment and Childhood Project, MIREC Maternal-Infant
Research on Environmental Chemicals, MSCEHS Mount Sinai Children’s Environmental Health Study, OCC Odense Child Cohort, S-MBS Shanghai-Minhang
Birth Cohort Study, SFFII Study for Future Families II
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sexually-dimorphic brain areas and behaviors [5]. Re-
garding cognition, we are not aware of previously pub-
lished results for BPA in the same population studied by
Grohs and coworkers [1].
Based on the commented epidemiologic evidence
(Table 1 and Supplementary Appendix), five emerging
patterns can be proposed: i) Most studies have reported
associations between prenatal BPA exposure and chil-
dren’s behavioral problems; ii) Prenatal BPA exposure is
more consistently associated with children’s behavior
than postnatal exposure; iii) BPA exposure is more fre-
quently associated with externalizing/internalizing prob-
lems than cognitive outcomes; iv) Both internalizing and
externalizing symptoms seem to coexist; and v) Associa-
tions usually, but not always, differ by sex.
With the exception of the HOME, CHAMACOS and
INMA-Sabadell birth cohorts, which assessed prenatal
urinary BPA concentrations at two-three time points
during gestation, the remaining studies collected one
spot urine sample, in either the second or third trimester
to characterize BPA exposure (Table 1). Grohs et al. also
used one urine sample [1]. Since BPA is rapidly metabo-
lized and excreted in urine, and exposure patterns are
episodic, using one spot urine sample may lead to expos-
ure misclassification. This means that when all studies in
a given field are taken together, there is a greater ten-
dency to obtain null results, the so-called attenuation
bias [6]. In other words, most of the associations ob-
served with behavior would be systematically underesti-
mated. Despite this limitation, the increasing consistency
of patterns observed across different human populations
probably reflects the tip of the iceberg. This important
aspect should be carefully considered when interpreting
the epidemiologic literature.
Biological plausibility
That prenatal BPA exposure impairs offspring’s brain
and behavior in experimental animals through different
mechanisms is a fact difficult to neglect based on dozens
of independent academic peer-reviewed studies [4]. Sur-
prisingly, most of these studies have not been usually
considered by risk assessors, based on issues related to
study design, animal strains, animal number per dose
group, and/or the endpoints investigated (i.e. molecular
and functional changes vs. gross endpoints such as organ
weights) [7]. To reconcile these divergent views, the Con-
sortium Linking Academic and Regulatory Insights on
BPA Toxicity (CLARITY-BPA), was developed by three
US agencies (National Institute of Environmental Health
Sciences – NIEHS; National Toxicology Program – NTP;
and US Food and Drug Administration – FDA). Briefly,
CLARITY-BPA conducted a traditional regulatory-style
toxicology study in an FDA facility, known as the “core”
study, in conjunction with academic laboratories to test
previous hypothesis following the same protocol, and
sharing the same animals and/or tissues [7]. CLARITY-
BPA evaluated a wide range of BPA doses (2.5, 25, 250,
2500, or 25,000 μg/kg per day). Although this dose range
is several orders of magnitude higher than the human ex-
posure range, the two lowest BPA doses tested are consid-
ered of relevance to humans.
In the CLARITY-BPA program, the developing
brain has again emerged as probably the most sensi-
tive organ disrupted by BPA, as reviewed in detail by
Patisaul [7]. The most consistent finding between pre-
vious experimental studies and CLARITY-BPA data is
that prenatal exposure to the lowest BPA dose tested
(2.5 μg/kg per day) was able to alter the gene expres-
sion of estrogen receptors (ERs) in multiple brain re-
gions [7], in line with alterations in the volume of the
anteroventral periventricular (AVPV) nucleus of the
hypothalamus, implicated in sexually dimorphic physi-
ology and behaviors [7]. Untargeted transcriptomics
additionally identified the highest number of differen-
tially expressed genes in the male hypothalamus and
female amygdala [7]. However, in contrast to previous
findings showing effects of developmental BPA
exposure on anxiety and exploratory behaviors,
CLARITY-BPA found subtle and sporadic behavioral
modifications [7]. Importantly, expected normal be-
havioral differences between male and female animals
in the unexposed controls were not detected, suggest-
ing some specificities of the Sprague-Dawley (SD) rat
strain used, which appeared to be quite insensitive to
test BPA-related sex-specific behavioral outcomes pre-
viously observed in other SD strains [7].
Overall, CLARITY-BPA supports that in utero BPA
exposure could predispose later responses in sexually di-
morphic brain areas to estradiol and other hormones
throughout development, providing a mode of action for
BPA effects on brain and behavior. Results from this
consortium also highlights that the expected endpoints
are subtle modifications in neuroendocrine function and
behavior, rather than gross alterations in brain weight
among other overt damages [7, 8]. However, these subtle
modifications are not usually evaluated in regulatory
studies, and therefore should be systematically collected
from the available peer-reviewed academic studies.
Some of the lessons derived from the CLARITY-BPA
program include: i) The existence of low-dose BPA ef-
fects that were not predicted by higher doses; ii) Un-
equivocal alterations of ER expression across the rat
brain; and iii) Multiple low-dose adverse effects, includ-
ing the mammary gland, prostate, kidney and body
weight among others [7, 8].
Among the concerns raised by CLARITY-BPA are the
animal strain used, and probably the particular lineage of
that strain, which seems to influence the specific effects
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observed in response to BPA. Apart from the abovemen-
tioned lack of normal sexually-dimorphic behaviors in the
experimental animals, the strain used in CLARITY-BPA
was also quite insensitive to low doses of known estrogens
such as ethynyl estradiol (EE) [8]. These limitations could
be counteracted by adopting an integrative and systematic
approach to gather available animal data from several
strains, considering the whole academic literature between
BPA exposure and neurotoxicity.
Although animal research provides invaluable informa-
tion on modes of action and potential adverse effects,
there are inherent limitations when extrapolating results
from experimental animal models to humans. The dif-
ference is maximized in the case of brain structure and
function. For example, testosterone is aromatized to es-
tradiol, masculinizing the rodent brain acting through
ERs [7, 9]. On the contrary, the sexual differentiation of
the primate and human brain appears to be primarily
driven by testosterone acting without an estrogen inter-
mediary [10, 11]. Consequently, the sexually dimorphic
brain and behavioral effects frequently reported for BPA
in both rodents [4] and humans [2] could be compared
to some extent, but perhaps not in the same direction
nor occurring through the same mechanisms of action.
Based on the previous limitations, the translatability of
CLARITY-BPA and animal models to humans has been
questioned [12]. Thus, Hagobian (2019) argues that to
truly understand its health risks, BPA should be admin-
istered to humans under controlled conditions [12]. Al-
though a preliminary intervention trial dosing adult
human volunteers with BPA has shown short-term alter-
ations in glucose and insulin parameters [12], this ap-
proach appears unacceptable in pregnant women due to
the potential risk of teratogenic and long-lasting effects
on the offspring. Therefore, the valuable information
available for BPA from mother-child birth cohort studies
should be carefully considered in decision-making.
Human evidence in risk assessment
To understand the available human data, there are sev-
eral contextual characteristics that must be considered
when interpreting the relationship between BPA expos-
ure and children’s neurobehavior (Table 2). More than
90% of Europeans and Americans have detectable con-
centrations of BPA in their urine, and diet is considered
the main -but not unique- contributor to exposure levels
[2]. The expected consequences of human BPA exposure
would be subtle effects at the subclinical level, in line
with results at low-doses from the CLARITY-BPA pro-
gram. However, given that BPA exposure is universal
and chronic, even if subtle effects were occurring, they
could affect the whole human population, with a special
emphasis on the developing fetus.
The multiple mechanisms of action on the brain de-
scribed for BPA mean that different brain areas and be-
havioral patterns could be affected depending on the
particular window of brain development and susceptibil-
ity [4]. In relation to Grohs et al. findings, the develop-
ment of the human splenium is thought to emerge
around the weeks 18–19 of gestation [13], just the crit-
ical window in which the authors assessed prenatal BPA
exposure [1]. Exposure during other periods could be
linked to changes in other brain areas and/or behavioral
domains.
There is consensus that twenty-first century chemical
risk assessments need to integrate multiple streams of
evidence (mechanistic, animal, and epidemiology data)
[14], and systematic frameworks to achieve this objective
have been proposed [15]. However, risk assessors seem
to still remain reluctant to integrate human data, based
on the limitations of observational studies. Thus, the re-
cent report of the European Food and Safety Authority
(EFSA) on the study appraisal methodology for the
forthcoming BPA risk assessment, has included an “all-
or-nothing” judgment for the selection of observational
studies: [“only studies using a minimum of three time 24-
hour urine samples could be considered as reliable (+ or
++)”] [16]. Following this criterion, it is currently not
possible to find any human study in the PubMed data-
base. This means that, out of hundreds of epidemiologic
studies available for BPA, none will be considered during
the next risk assessment. Is there a scientific rationale to
support this highly exclusive exposure criterion? Unfor-
tunately, we could not find any strong justification be-
hind this decision throughout the report, nor any
reference in the bibliographic list focused on the expos-
ure characterization of BPA [16]. This vague but decisive
requisite appears in the best of the cases thoughtless,
and biased in the worst.
The strict exclusion criterion followed in the EFSA re-
port [16] seems to be based on findings from Sun et al.
[17]. Although the authors estimated that three 24-h
urine samples collected throughout a year could provide
a theoretical intraclass correlation coefficient (ICC) near
to 0.8 (i.e. attenuation bias would be limited to 20%),
they reported an empirical ICC of 0.39 for BPA using
two 24-h urine samples [17]. This empirical ICC is con-
sidered low to moderate, and not optimal to substantiate
the strict criterion proposed by the EFSA report [16],
even more when the collection of 24-h urine samples in
population studies is cumbersome and very rarely per-
formed. Moreover, the unique study that has so far eval-
uated BPA using four 24-h urine samples collected over
1 year, reported an ICC of 0.57 [18]. On the contrary, re-
cent empirical research shows that the most important
aspect is to count with a higher number of urine sam-
ples collected during the expected critical window, but
Mustieles and Fernández Environmental Health           (2020) 19:66 Page 5 of 8
not necessarily 24-h samples [6]. Thus, Vernet and col-
leagues have demonstrated the feasibility of collecting
multiple repeated spot urine samples during gestation,
and pooling them to provide a cost-effective measure-
ment, achieving an ICC higher than 0.8 for BPA [6].
Human BPA exposure characterization is challenging
due to the episodic nature and rapid metabolization of
this compound. We agree that exposure characterization
must be improved as much as possible for short-lived
chemicals with high within-individual variability such as
BPA [6], and that more weight must be given to studies
using several urine samples compared to those only
using one. Our disagreement with the EFSA report [16]
lies on an imprudent dismissal of all the human BPA
evidence based on non-justified criteria. Indeed, one of
Bradford Hill’s criteria for assessing causality in observa-
tional studies is some consistency and coherence across
different populations. Thus, for a specific outcome such
as children’s behavior, even if one study would have
assessed prenatal BPA exposure using three 24-h urine
samples throughout pregnancy, it would not be as in-
formative as 10 studies evaluating prenatal BPA expos-
ure using only one spot urine sample.
The trend in future cohort studies, the so-called “third
generation cohorts” such as the recent SEPAGES cohort
in France [19], will be to provide a greatly improved ex-
posure characterization to non-persistent chemicals
through repeated sampling and subsequent pooling of
spot urine samples in order to counteract the expected
attenuation bias, while maintaining cost-effectiveness.
Ironically, a hypothetical future “third generation cohort”
study reporting associations between prenatal exposure
to BPA and child behavior problems using this improved
exposure characterization strategy would also be
excluded from the forthcoming EFSA assessment [16].
Regarding the last characteristic of the BPA-
neurobehavior context, human BPA exposure never oc-
curs in isolation, but instead in complex low-dose chem-
ical mixtures, with often unpredictable consequences.
Arguably, co-exposure to dozens of environmental chemi-
cals with described neurotoxic potential is expected to
converge and sum up to BPA’s adverse effects on the brain
[20]. A special consideration for real-world mixtures, per-
haps through an additional safety factor may be proposed
in future risk assessments.
Novel biomarkers of brain structure/function vs.
neurobehavioral tests
There is no perfect tool for assessing the effects of endo-
crine disruptors on neurodevelopment. Validated ques-
tionnaires, such as the CBCL, are widely used to assess
children’s behavior in epidemiologic studies for practical
reasons, providing very useful information [2]. However,
these tests are usually completed by parents and/or
teachers, who are not free from a subjective perception
of their child’s behavior, and although validated, have
been considered as a limitation in previous EFSA risk as-
sessments [“imprecise/unreliable outcome (neurobehav-
ioral parameters scored using parent-reported but
validated methods)”, Appendix D.1.3] [16]. Despite po-
tential limitations, questionnaire data should be given
full consideration in risk assessment. A repeated longitu-
dinal assessment of child behavior trajectory is preferred
and feasible in mother-child cohorts [21]. This is im-
portant since in utero BPA exposure is expected to
cause “organizational” effects in the brain, as supported
by animal studies as well as Grohs et al. findings [1], po-
tentially explaining long-lasting effects on children’s be-
havior [21].
Apart from neuropsychological tests, the implemen-
tation of complementary measurements such as MRI
scan by Grohs et al. offers an objective and low-
invasive measure of brain microstructure that comple-
ments and enriches previous data [1]. Of outermost
importance, differences in particular brain tracts me-
diated BPA associations with children’s behavior, pro-
viding a neural correlate that supports functional
changes in behavior and increases the confidence in
Table 2 Key characteristics of the BPA-neurobehavior context, and their implications for interpreting the available human evidence
BPA Neurobehavior Implications
Ubiquity Exquisite sensitivity of the developing brain The whole population may be at risk, with a special consideration for
the developing fetus
Low-dose effects cannot
always be predicted from
high doses
Non-traditional endpoints such as behavior
and molecular brain changes are more
realistic
Subtle subclinical effects at a population level are expected, rather
than obvious clinical effects at the individual level




Indirect behavior assessment with
questionnaires completed by parents or
teachers
The expected bias arising from limitations when evaluating both BPA




Organizational vs. activational effects in the
brain
Human BPA exposure always coexist and probably interacts with many
other chemicals. Prenatal exposures may “organize” brain areas, leading
to long-lasting effects in the offspring
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these findings [1]. Established mother-child birth co-
horts in which MRI scans have been already
performed in hundreds of children may constitute a
timely and cost-effective opportunity to confirm the
path started by Grohs and colleagues.
The investigation of potential intermediate molecu-
lar biomarkers of brain function, which may biologic-
ally support associations with child behavior,
constitutes a complementary area of emerging inter-
est. For example, brain-derived neurotrophic factor
(BDNF) constitutes a promising effect biomarker
candidate. In utero BPA exposure has been shown to
induce DNA methylation changes in the transcrip-
tionally relevant region of the BDNF gene in the
hippocampus of mice, which correlated with its
methylation status in blood [22]. Moreover, consistent
BDNF DNA methylation changes in the cord blood of
children prenatally exposed to higher maternal BPA
concentrations were also shown [22]. The implemen-
tation of novel biomarkers of brain function is being
studied under the umbrella of the Human Biomoni-
toring for Europe (HBM4EU) initiative, in which
BDNF, as well as other related biomarkers, will be
assessed in different European populations, and at dif-
ferent levels of biological organization (DNA, RNA,
circulating protein levels, etc.) [23]. At the same time,
adverse outcomes pathway (AOP) networks support-
ing the implementation of these biomarkers are being
developed [23]. As an advantage compared to brain
structure measurements, molecular biomarkers can be
assessed at a large scale and in accessible biological
samples such as blood.
Conclusions
All fields are subjected to inherent limitations. Cell-
based models explore mechanisms of action, normally at
high doses that cannot be easily extrapolated to humans,
neither account for complex homeostasis. Animal
models provide information on the whole organism, but
translatability is not warranted. At this stage, it is impos-
sible to ignore the growing epidemiological evidence
linking prenatal BPA exposure with children’s behavior.
However, this literature has not been adequately consid-
ered in risk assessment. Lack of data is no longer a prob-
lem. How the available data is compiled, selected and
interpreted is the key issue explaining divergent evalua-
tions. To avoid a myopic or biased selection of a few
studies in traditional risk assessment procedures, we
propose a future BPA reevaluation focused on neurotox-
icity and based on a systematic and comprehensive inte-
gration of available mechanistic, animal, and human data
[15]. Even in the face of uncertainties, we especially
highlight the need to adequately assess the growing epi-
demiologic literature between prenatal BPA exposure
and children’s behavior for decision-making. This im-
plies the active participation of experienced epidemiolo-
gists in future BPA risk assessments. When both the
context and data are taken together, the in vitro, in vivo
rodent, some non-human primate studies and a growing
epidemiologic evidence from birth cohorts converge into
the same direction: BPA is a probable developmental
neurotoxicant at low doses [2–4, 7]. Radical measures
do not appear realistic or the best solution. But inaction
at this point may be irresponsible. Accordingly, the pre-
cautionary principle must be followed and stringent pre-
ventive policies, such as the banning of BPA in food
contact materials and thermal receipts, should be pro-
gressively implemented worldwide with a focus on the
utilization of safer substitutes.
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